We’re proud to share that 4bases presented a scientific poster introducing InnoGraft — our innovative, minimally invasive solution for monitoring graft rejection in organ transplant patients. Congrats and thanks to the authors: Stefano Casali, Giulia Mazzucco, Andrea Degiorgi and Valentina Favalli
What is InnoGraft?
InnoGraft quantifies donor-specific cell-free DNA (cfDNA) from blood samples, offering a precise and biopsy-free way to monitor transplant rejection across different organ types.
Using a targeted SNP panel combined with AI-powered analysis, InnoGraft delivers accurate detection of donor cfDNA — helping clinicians make informed decisions, faster and with greater confidence.
We’re thrilled to be part of the ESOT – European Society for Organ Transplantation Congress, contributing to the future of transplant medicine through innovation and collaboration.
If you’re attending ESOT, stop by booth A42 to learn more!
